Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral clindamycin versus oral metronidazole for bacterial vaginosis in pregnant women
PACTR202208601005566Phase 3Unknown
- Sponsor
- Dr Otobong Peter Asuquo
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of clindamycin and metronidazole in bacterial vaginosis (BV) (2 arms), sponsored by Dr Otobong Peter Asuquo. Status: unknown.
02
Drugs
clindamycinmetronidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on PACTR202208601005566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202208601005566.